Welcome to our dedicated page for Cannabist SEC filings (Ticker: CBSTF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cannabist Company Holdings Inc. (CBSTF) files a range of reports and disclosures with the U.S. Securities and Exchange Commission that shed light on its cannabis operations, capital structure and governance. As a British Columbia corporation with U.S. reporting obligations, its SEC filings help investors understand how the company manages its multi-state cultivation, manufacturing and retail footprint.
On this page, you can review current and historical SEC filings for The Cannabist Company, including Form 8-K reports detailing material events. Recent 8-K filings describe equity purchase agreements to sell the company’s Virginia subsidiary, Green Leaf Medical of Virginia, LLC, first to Curaleaf, Inc. and later to an entity affiliated with Millstreet Credit Fund LP, along with the termination of the Curaleaf agreement and related break-up fee. Other 8-Ks discuss the formation of a special committee to review strategic alternatives, the election not to make an interest payment on senior secured notes within the initial due date, and the resulting 30-day grace period under the indenture.
Filings also cover governance and compensation matters, such as board election results at the annual general meeting, the resignation of a co-founder from the Board of Directors, the transition of the Chief Financial Officer to a consulting role, and the adoption of a key employee retention bonus program that replaced a prior transaction bonus plan. These documents provide context on how the company is addressing leadership continuity and retention during its strategic review.
In addition to event-driven 8-Ks, investors can access quarterly and annual reports referenced in the company’s press releases. These filings include discussions of revenue, margins, non-GAAP measures such as Adjusted EBITDA and Adjusted Gross Profit, and risk factors related to cannabis regulation, taxation and financing.
Stock Titan’s platform presents these filings with AI-powered summaries that highlight key terms, transaction structures, grace periods, and board or executive changes. Real-time updates from EDGAR, along with structured access to material contracts and event disclosures, help users quickly identify developments affecting The Cannabist Company’s notes, asset sales, governance and strategic alternatives.
Cannabist Co Holdings Inc. insider David Sirolly, the company's Chief Legal Officer and General Counsel, reported a transaction dated 09/30/2025 on SEC Form 4. The filing shows 962 common shares were acquired at an effective price of $0.073 per share under transaction code F. The form's explanatory note states these shares represent amounts withheld by the issuer to satisfy tax obligations at the time of share settlement for annual equity grants. After this activity, Mr. Sirolly beneficially owns 1,130,779 common shares. The Form 4 is individually filed and is signed by Mr. Sirolly on 10/02/2025.
Cannabist Co Holdings Inc. (CBSTF) reporting person Rosemary Mazanet notified the company that she ceased to be a director on September 24, 2025. The Form 4 contains no reported purchases or sales of issuer securities; the filing is signed by an attorney-in-fact on behalf of Ms. Mazanet on September 26, 2025.
Alison Worthington, a reporting person for Cannabist Co Holdings Inc. (CBSTF), reported on Form 4 that 805,264 restricted stock units (RSUs) were treated as acquired on September 24, 2025 under transaction code M. Each RSU represents a contingent right to one share of common stock. Following the reported transaction, Worthington beneficially owned 1,279,204 common shares directly. The RSUs were originally granted on June 26, 2024 and fully vested on the date of the issuer’s 2025 annual meeting; settlement will occur as soon as administratively feasible after vesting.
James A.C. Kennedy, an officer and former director of Cannabist Co Holdings Inc. (CBSTF), reported a Section 16 transaction on 09/24/2025 showing the acquisition of 805,264 restricted stock units (RSUs) which represent the right to receive one share each. The filing states these RSUs were granted on June 26, 2024 and fully vested on the date of the issuer's 2025 annual meeting. Following the transaction the reporting person’s beneficial ownership is listed as 3,185,817 common shares. The RSUs will be settled as soon as administratively feasible. The form was signed by an attorney-in-fact on 09/26/2025.
The Cannabist Company Holdings Inc. reported the results of its annual general meeting of shareholders held virtually on September 26, 2025. Shareholders elected seven directors to serve until the next annual meeting or until their successors are chosen, including Michael Abbott, Jeff Clarke, David Hart, Julie Hill, Peter Lee, Thomas Lynch, and Jonathan P. May. Support levels varied by nominee, with Peter Lee and Thomas Lynch each receiving 146,958,000+ votes in favor.
Shareholders also approved the re-appointment of PKF O’Connor Davies, LLP as the Company’s auditor until the next annual meeting. The auditor proposal received 256,774,373 votes for, 0 votes against, and 4,201,615 abstentions, indicating strong shareholder support for continuing with the current audit firm.